Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

RadExIORSBoost

Financiado

Twinning to skyrocket scientific excellence towards individual radiosensitivity...

Twinning to skyrocket scientific excellence towards individual radiosensitivity prediction by raising the bar in knowledge transfer, networking, and technological innovation in radiobiology Prostate cancer patients receiving radiotherapy (RT) may develop radiation-induced side effects, which significantly impact quality of life. One of the main challenges in radiobiology is to predict individual patient's normal tiss... ver más

30/09/2027

INSTITUTE OF ONCOL...

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

INSTITUT ZA ONKOLOGIJU I RADIOLOGIJU SRBIJE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 5 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-22

HORIZON-WIDERA-2023-ACCESS-02-01: Twinning Bottom-Up ExpectedOutcome:For the first time this Twinning call adopts a partially directional approach allowi...

Innovación

Cerrada hace 1 año

0% 100% 100%

5 Participantes

INSTITUTE OF ONCOLOGY AND RA...

502.56K€ | Lider

MEDIZINISCHE UNIVERSITAET WI...

200.35K€ | Participante

UHEI

330.10K€ | Participante

OI LJUBLJANA

190.63K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

FG_WIT AUTOMATED PROTOTYPE OF CANCER DETECTION FROM CTDNA 75K€ Cerrado

PLEC2022-009476 Advanced dosimetry for novel radiotherapy approaches in brai... 307K€ Cerrado

PDC2021-121424-I00 BIOPSIA Y TEJIDO EN UN CHIP MAS BIOSENSORES MULTIPLEXADOS IN... 138K€ Cerrado

PID2019-105789RB-I00 ROBUST RADIOMIC FEATURES WITH CLINICAL DATA MODELLING FOR CH... 84K€ Cerrado

CANCER-ID Cancer treatment and monitoring through identification of ci... 21M€ Cerrado

SAF2015-66084-R AVANZANDO EN LA INTERPRETACION DE GENOMAS DE TUMORES PARA ME... 290K€ Cerrado

Duración del proyecto: 40 meses Fecha Inicio: 2024-05-22
Fecha Fin: 2027-09-30

Líder del proyecto

INSTITUT ZA ONKOLOGIJU I RADIOLOGIJU SRBIJE No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto Prostate cancer patients receiving radiotherapy (RT) may develop radiation-induced side effects, which significantly impact quality of life. One of the main challenges in radiobiology is to predict individual patient's normal tissue radiosensitivity to tailor personalized RT. Although the Institute for Oncology and Radiology of Serbia (IORS) is a highly specialized health, scientific, and educational institution it is necessary to develop a strategic action plan and sustainable knowledge transfer networking with top-class leading European institutions. Through the 6 Specific Objectives, RadExIORSBoost project aims to develop and implement institutional Scientific Strategy on radiobiology, to investigate individual radiosensitivity by transcriptome profiling, radiation-induced lymphocyte apoptosis, and measurement of DNA damage levels, to design a high-quality clinical study, and to raise the research capacity of IORS and partner institutions through 5 international workshops, 8 short-term visits, and 6 trainings. RadExIORSBoost project aims to strengthen the administrative and research management skills of IORS. RadExIORSBoost project realization will increase the scientific excellence of IORS to approach high-ranking partner institutions, Medical Faculty Mannheim, Heidelberg University (UHEI), Germany, the University of Leicester (ULEIC), United Kingdom, Medical University of Vienna, Center for Cancer Research, (MUW) Austria, and the Institute of Oncology Ljubljana (IOL) from Slovenia. Artificial intelligence-based models, such as machine learning may give directions towards the clinical application of peripheral blood mononuclear cell transcriptome, and list potential biomarkers predicting radiotoxicity, not only in cancer patients, but also in healthy individuals at risk. RadExIORSBoost project may blaze the trail for technological innovations in modern radiation oncology to significantly reduce the side effects of RT and its harmful effects on the environment.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores